Today's Information |
Provided by: TTY BIOPHARM COMPANY LIMITED | |||||
SEQ_NO | 2 | Date of announcement | 2022/03/09 | Time of announcement | 21:03:10 |
Subject | To announce the change of General Manager | ||||
Date of events | 2022/03/09 | To which item it meets | paragraph 6 | ||
Statement | 1.Date of the board of directors resolution or date of occurrence of the change:2022/03/09 2.Position (Please enter chairperson or president/general manager): General manager 3.Name of the previous position holder:Lin, Chuan 4.Resume of the previous position holder: Chairman of TTY Biopharm Company Limited 5.Name of the new position holder:Hou, Ching-Lan 6.Resume of the new position holder: Head of Asian oncology division, Novartis 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired" , "job relocation", "severance", "retirement", "death" or "new appointment"):New appointment 8.Reason for the change:New appointment 9.Effective date of the new appointment:2022/04/18 10.Any other matters that need to be specified:None. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
TTY Biopharm Co. Ltd. published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 13:21:09 UTC.